SLBST Pharma’s Post

View organization page for SLBST Pharma, graphic

233 followers

Excited to talk about our advances in treatment in Part Three of the Endometriosis Series on June 13th! Looking forward to learning more about diagnosing endo in Part Two of the Endometriosis Series presented by the Emerging Femtech 2024 Speaker Series.

View organization page for Emerging FemTech, graphic

245 followers

📣 Excited to announce the continuation of the Emerging Femtech 2024 Speaker Series with the Endometriosis Series: Innovators in Femtech! 🙌 Join us for insightful discussions on endometriosis diagnostics, access to care, and treatment innovations, featuring passionate entrepreneurs in the field.  ### Part Two: Diagnostics and Access to Care 🗓️ Date: June 3rd, 2024 ⏰ Time: 6-7 PM ET 📍 Platform: Zoom Featuring: - Ridhi Tariyal, CEO and Co-Founder of NextGen Jane, a menstrual data platform characterizing uterine biology at the molecular level - Yana Aznavour, MD, PhD ObGyn, Gynecological Surgeon, CEO & Founder of Endometrics, specializing in non-invasive diagnostic tests using menstrual blood -Jessica Ellen King, CEO of Flowintell, focusing on endometriosis detection, advocacy, and support. ### Part Three: Treatment and Care 🗓️ Date: June 13th ⏰ Time: 6-7 PM ET 📍 Platform:  Zoom Featuring: - Catherine Hendy, Co-founder of ELANZA Wellness, focusing on endometriosis symptom management through the Everything Endo app. - Mark Connell, President and Co-Founder of SIbst Pharma, repurposing hydroxychloroquine (HCQ) as an immunomodulator for treatment. 👉 RSVP here👈 Part Two: https://lnkd.in/eSKDJ-iF   Part Three: https://gforms.app/KC0hLrq   We look forward to seeing you online! #EmergingFemtech #Endometriosis #WomensHealth #HealthcareInnovation Supported by:Harvard GSAS Business Club |Harvard Mignone Center for Career Success Organizing team: Heer Joisher | Kimia Sorouri, MD, MPH | Sharan Rai, PhD | Katherine Suarez | Nivedhitha Velayutham, PhD | Tina Yi-Jin Hsieh, MD MPH

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics